Karen M. Fancher, Pharm.D., BCOPAssistant Professor of Pharmacy Practice
Clincal, Social and Administrative Sciences
Education:Pharm.D., Duquesne University, 1999
B.S. Pharmacy, Duquesne University, 1998
Karen Fancher, Pharm.D., BCOP, Assistant Professor of Pharmacy Practice in Oncology Acute Care joined the Mylan School of Pharmacy on December 3, 2012. She is a graduate of Duquesne University and completed a Pharmacy Practice Residency at Thomas Jefferson University Hospital in Philadelphia, followed by a Specialty Residency in Oncology Pharmacy Practice at the H. Lee Moffitt Cancer Center & Research Institute in Tampa. She then spent almost 10 years as a Clinical Pharmacist in the Blood & Marrow Transplant Division at the H. Lee Moffitt Cancer Center before returning to Pittsburgh to work with the West Penn Allegheny Oncology Network. Dr. Fancher's current practice site is the University of Pittsburgh Medical Center at Passavant Hospital. She serves on the Hematology Oncology Pharmacy Association's CE Accreditation Review Panel, routinely lectures at both the collegiate and national levels, and has been nominated for ASHP's Preceptor of the Year Award. Dr. Fancher's research interests include hematopoietic stem cell transplantation and the management of chronic iron overload.
"The Basics: Overview of Lung Cancer" - ACPE-accredited invited lecture at the 2013 Hematology Oncology Pharmacists Association Annual Meeting. Los Angeles, CA, March 2013.
"Lymphomas" - invited lecture at the Fundamentals of Chemotherapy and Targeted Therapy Course at the Western Pennsylvania Hospital. Pittsburgh, PA, February 2012.
"Oncologic Emergencies" - invited lecture to the Comprehensive Emergency Nursing Course at The Western Pennsylvania Hospital School of Nursing. Pittsburgh, PA, April 2011.
"Supportive Care of the Outpatient Oncology Patient" - ACPE-accredited lecture at the 2011 Duquesne University Mylan School of Pharmacy Annual Alumni Conference. Pittsburgh, PA, March 2011.
"NAPLEX Oncology Review" - Duquesne University Mylan School of Pharmacy, November 2010, May 2011, June 2011, October 2011 and May 2012.
"Iron Overload in Hematopoietic Stem Cell Transplant Patients" - invited lecture at H. Lee Moffitt Blood & Marrow Transplant Grand Rounds. Tampa, FL, March 2009.
"Incorporation of Aprepitant into Hematopoetic Stem Cell Transplant Conditioning Regimens" - ACPE-accredited invited lecture at the 2009 American Society for Bone Marrow Transplantation Tandem Meeting. Tampa, FL, February 2009.
"Chemotherapy Induced Nausea & Vomiting" - expert presenter for the University of Florida College of Pharmacy, April 2010 and October 2008; and Lake Erie College of Medicine (LECOM) School of Pharmacy, April 2010.
"Hematopoietic Stem Cell Transplantation" - expert presenter for Lake Erie College of Medicine (LECOM) School of Pharmacy, April 2010; and the University of Florida Working Professional PharmD program (PHA 5997), October 2008.
"Infections in Immunocompromised Patients" - expert presenter for the University of Florida Working Professional PharmD program (PHA 5597), October 2008, March 2005 and March 2003; and the University of Florida College of Pharmacy, April 2010 and October 2008.
"Management of Chemotherapy-Induced Nausea & Vomiting" - ACPE-accredited lecture at the 31st Annual Clinical Pharmacy Symposium, "Cancer 2008: Addressing Cancer-Related Health Disparities through a Multidisciplinary Approach," Florida A&M University. Tallahassee, FL, February 2008.
"Bone Marrow Transplantation for Beginners" - ACPE-accredited invited lecture at the Hematology / Oncology Pharmacy Association's Third Annual Conference. Denver, CO, June 2007
"Utilization of Different Doses of Prophylactic IV Acyclovir in a BMT Population" - Rebecca Tombleson, Karen Fancher, Janelle Perkins, et al. - poster presentation, 2010 Hematology Oncology Pharmacy Association. New Orleans, LA, March 2010.
"Pretransplant Factors That Influence Intravenous Busulfan Kinetics in Adult Patients" - Ali McBride, Karen Fancher, Jongphil Kim, et al. - poster presentation, 2009 American Society of Hematology. New Orleans, LA, December 2009.
"A Retrospective Analysis of Risk Factors That Influence Intravenous Busulfan Kinetics in Adult Patients," Ali McBride, Karen Fancher, Janelle Perkins, Amy Woodard, Michelle Conwell - poster presentation, 2009 Hematology / Oncology Pharmacy Association annual meeting. Miami, FL, June 2009.
"Safety Profile of Pharmacokinetically Targeted Intravenous Busulfan Combined with Fludarabine (BuFlu) as Conditioning Prior to Allogeneic Peripheral Blood Hematopoietic Cell Transplant," Janelle Perkins, Melissa Alsina, Ernesto Ayala, Karen Fancher, et. al. - poster presentation, 2009 Tandem BMT Meetings. Tampa, FL, February 2009.
"Retrospective Case Series of Allogeneic Stem Cell Transplantation in Patients with Multiple Myeloma at a Comprehensive Cancer Center," Jatandra L. Owens Birney, Karen M. Fancher and Janelle Perkins - poster presentation, Hematology / Oncology Pharmacy Association's Third Annual Conference. Denver, CO, June 2007.
Green MR, Newton MD, Fancher KM. Off-target effects of BCR-ABL and JAK2 inhibitors. Manuscript in progress.
Fancher KM. Imatinib Mesylate for Adjuvant Therapy of GIST: A New FDA Approval. HOPA News 2012; 9 (2); 7.
Tombleson RL, Green MR, Fancher KM. Putting caution in TEAM: high-dose chemotherapy with autologous HSCT for primary central nervous system lymphoma. Bone Marrow Transplantation. 2012; 1-2. Advanced online publication March 19, 2012.
Perkins J, Field T, Kim J, Kharfan-Dabaja MA, Ayala E, Perez L, Fernandez H, Fancher K, et al. Pharmacokinetic monitoring of i.v. busulfan with fludarabine as conditioning before hematopoietic stem cell transplant: the effect of first-dose area under the concentration time curve on transplant-related outcomes. Bone Marrow Transplantation. 2010 Dec 6.
Contributing author in The Elsevier Regimens & Supportive Therapy sections for OncologySTAT.com. 2008 and 2011.
Stanford BJ, Fancher KM. Bone Marrow Transplantation. In: Kreiger J, ed. Concepts in Immunology, Fourth Edition. Bethesda: American Society of Health-System Pharmacists; 2008.
PHBM 427 - Biomedical Sciences & Therapeutics VI (Hematology/ Oncology/ Transplant/ Pulmonary)
Acute Care Concentration
Problem Based Learning Experiences
Abilities Based Learning Experiences
Nominated for American Society of Health-Systems Pharmacists (ASHP) Preceptor Excellence Award: Preceptor of the Year, Fall 2008.
Nominated for the H. Lee Moffitt Cancer Center & Research Institute Award of Excellence, December 2008.
Team Award winner, H. Lee Moffitt Cancer Center & Research Institute, September 2008.